The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
The healthcare industry is entering a transformative era with the emergence of digital technologies. Innovations such as wearable sensors to monitor vital signs and AI-powered...